Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 4
1982 4
1983 8
1984 7
1985 14
1986 7
1987 13
1988 8
1989 8
1990 6
1991 7
1992 8
1993 4
1994 7
1995 6
1996 6
1998 7
1999 3
2000 3
2001 2
2002 2
2004 1
2005 1
2007 1
2008 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Ambulatory chemotherapy.
Seymour MT, Slevin ML. Seymour MT, et al. Among authors: slevin ml. Clin Oncol (R Coll Radiol). 1992 Jan;4(1):1-3. doi: 10.1016/s0936-6555(05)80758-7. Clin Oncol (R Coll Radiol). 1992. PMID: 1736972 No abstract available.
Chemotherapy for stomach cancer.
Clark PI, Slevin ML. Clark PI, et al. Among authors: slevin ml. Br Med J (Clin Res Ed). 1987 Oct 10;295(6603):870-1. doi: 10.1136/bmj.295.6603.870-a. Br Med J (Clin Res Ed). 1987. PMID: 3119080 Free PMC article. Review. No abstract available.
Alternative cancer cures.
Farrugia D, Slevin ML. Farrugia D, et al. Among authors: slevin ml. Lancet Oncol. 2000 Dec;1:204-5. doi: 10.1016/s1470-2045(00)00147-9. Lancet Oncol. 2000. PMID: 11905634 No abstract available.
Chemotherapy in lung cancer.
Price CG, Slevin ML. Price CG, et al. Among authors: slevin ml. Postgrad Med J. 1989 May;65(763):291-8. doi: 10.1136/pgmj.65.763.291. Postgrad Med J. 1989. PMID: 2558370 Free PMC article. Review. No abstract available.
Schedule-dependent topoisomerase II-inhibiting drugs.
Joel SP, Slevin ML. Joel SP, et al. Among authors: slevin ml. Cancer Chemother Pharmacol. 1994;34 Suppl:S84-8. doi: 10.1007/BF00684869. Cancer Chemother Pharmacol. 1994. PMID: 8070033 Review.
Etoposide dosage and pharmacodynamics.
Joel SP, Shah R, Slevin ML. Joel SP, et al. Among authors: slevin ml. Cancer Chemother Pharmacol. 1994;34 Suppl:S69-75. doi: 10.1007/BF00684867. Cancer Chemother Pharmacol. 1994. PMID: 8070031 Review.
Cancer information: a cost-effective intervention.
Mossman J, Boudioni M, Slevin ML. Mossman J, et al. Among authors: slevin ml. Eur J Cancer. 1999 Oct;35(11):1587-91. doi: 10.1016/s0959-8049(99)00195-1. Eur J Cancer. 1999. PMID: 10673966 Review.
Ethical issues in cancer treatment.
Penson RT, Doyal L, Slevin ML. Penson RT, et al. Among authors: slevin ml. Br J Urol. 1995 Nov;76 Suppl 2:37-40. doi: 10.1111/j.1464-410x.1995.tb07869.x. Br J Urol. 1995. PMID: 8535752 Review. No abstract available.
The clinical pharmacology of etoposide.
Slevin ML. Slevin ML. Cancer. 1991 Jan 1;67(1 Suppl):319-29. doi: 10.1002/1097-0142(19910101)67:1+<319::aid-cncr2820671319>3.0.co;2-d. Cancer. 1991. PMID: 1984835 Review.
Carboplatin or cisplatin?
Calvert AH, Horwich A, Newlands ES, Begent R, Rustin GJ, Kaye SB, Harris AL, Williams CJ, Slevin ML. Calvert AH, et al. Among authors: slevin ml. Lancet. 1988 Sep 3;2(8610):577-8. doi: 10.1016/s0140-6736(88)92709-2. Lancet. 1988. PMID: 2900968 No abstract available.
137 results